117 related articles for article (PubMed ID: 6223817)
1. Behavior of some steroids in endometrial adenomatous and atypical hyperplasia.
Pelusi G; Moretti B; Martinelli G; Camerini T; Busacchi P; Cavallina R
Eur J Gynaecol Oncol; 1983; 4(2):131-4. PubMed ID: 6223817
[TBL] [Abstract][Full Text] [Related]
2. Serum estrogens and androgens in women with endometrial carcinoma.
Pettersson B; Bergström R; Johansson ED
Gynecol Oncol; 1986 Oct; 25(2):223-33. PubMed ID: 2944804
[TBL] [Abstract][Full Text] [Related]
3. Behaviour of some steroids in postmenopausal women with coelomic ovarian tumors.
Pelusi G; Moretti B; Cavallina R; Busacchi P; Martinelli G
Eur J Gynaecol Oncol; 1983; 4(3):224-8. PubMed ID: 6313369
[TBL] [Abstract][Full Text] [Related]
4. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
5. Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects.
Jasonni VM; Franceschetti F; Ciotti P; Bulletti C; Vignudelli A; Marabini A; Naldi S; Flamigni C
Acta Obstet Gynecol Scand; 1986; 65(7):685-7. PubMed ID: 2949483
[TBL] [Abstract][Full Text] [Related]
6. Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
Maroulis GB; Abraham GE
Obstet Gynecol; 1976 Aug; 48(2):150-4. PubMed ID: 133306
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural features of endometrial atypical adenomatous hyperplasia and adenocarcinomas and the plasma level of estrogens.
Klemi PJ; Grönroos M; Rauramo L; Punnonen R
Gynecol Oncol; 1980 Apr; 9(2):162-9. PubMed ID: 7372188
[No Abstract] [Full Text] [Related]
8. Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
Abraham GE; Maroulis GB
Obstet Gynecol; 1975 Mar; 45(3):271-4. PubMed ID: 163457
[TBL] [Abstract][Full Text] [Related]
9. Peripheral hormone levels and the endometrial condition in postmenopausal women.
Brody S; Carlström K; von Uexküll AK; Lagrelius A; Lunell NO; Rosenborg L
Acta Obstet Gynecol Scand; 1983; 62(5):525-9. PubMed ID: 6229973
[TBL] [Abstract][Full Text] [Related]
10. The role of androgens in the late-premenopausal woman with adenomatous hyperplasia of the endometrium.
Vitoratos N; Gregoriou O; Hassiakos D; Zourlas PA
Int J Gynaecol Obstet; 1991 Feb; 34(2):157-61. PubMed ID: 1671371
[TBL] [Abstract][Full Text] [Related]
11. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
[TBL] [Abstract][Full Text] [Related]
12. [Plasma concentration of estrogens and androgens in postmenopausal women with or without endometrial cancer].
Nagasako S; Asanuma N; Nagata Y
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jun; 40(6):707-13. PubMed ID: 3292674
[TBL] [Abstract][Full Text] [Related]
13. Plasma estrogens and androgens in male breast cancer.
Calabresi E; De Giuli G; Becciolini A; Giannotti P; Lombardi G; Serio M
J Steroid Biochem; 1976 Aug; 7():605-9. PubMed ID: 134178
[No Abstract] [Full Text] [Related]
14. How effective is surgical adrenalectomy in lowering steroid hormone concentrations?
Worgul TJ; Santen RJ; Samojlik E; Wells SA
J Clin Endocrinol Metab; 1982 Jan; 54(1):22-6. PubMed ID: 6459336
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting sex hormone levels in postmenopausal women.
Vermeulen A; Verdonck L
J Steroid Biochem; 1979 Jul; 11(1C):899-904. PubMed ID: 491650
[No Abstract] [Full Text] [Related]
16. Age, steroids and bone mineral content.
Rozenberg S; Ham H; Bosson D; Peretz A; Robyn C
Maturitas; 1990 Jun; 12(2):137-43. PubMed ID: 2147737
[TBL] [Abstract][Full Text] [Related]
17. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
[TBL] [Abstract][Full Text] [Related]
18. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
19. Plasma oestrogens in postmenopausal women with endometrial cancer.
Nyholm HC; Nielsen AL; Lyndrup J; Dreisler A; Hagen C; Haug E
Br J Obstet Gynaecol; 1993 Dec; 100(12):1115-9. PubMed ID: 8297845
[TBL] [Abstract][Full Text] [Related]
20. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?
Labrie F; Martel C; Balser J
Menopause; 2011 Jan; 18(1):30-43. PubMed ID: 20683211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
